Form D · Venture Capital Fund

SV Biotech Crossover Opportunities Fund LP

London, X0 · CIK 0001903934

Offering snapshot reported Jan 18, 2022 · SEC filing

Reported sold
$135M
Offering amount: $350M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 18, 2022Initial$135,180,000No comparison7SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-429725
Includes subscriptions pursuant to Rule 506(b) and Regulation S.

Source: Form D, filed Jan 18, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SV BIOTECH CROSSOVER OPPORTUNITIES FUND LP

Investment adviser: SV HEALTH MANAGERS LLP

Gross asset value
$303M
Beneficial owners
15
ADV minimum commitment
$5M

Reported in Form ADV on Mar 24, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator AZTEC FINANCIAL SERVICES (UK) LIMITED FAREHAM, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor RSM UK AUDIT LLP LONDON, United Kingdom
Custodian AZTEC FINANCIAL SERVICES (UK) LIMITED FAREHAM, United Kingdom Related to adviser: No
Custodian BARCLAYS BANK PLC LONDON, United Kingdom Related to adviser: No
Custodian MORGAN STANLEY SMITH BARNEY LLC PURCHASE, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

RSM UK AUDIT LLP
PCAOB 1545

BARCLAYS BANK PLC
LEI G5GSEF7VJP5I7OUK5573

MORGAN STANLEY SMITH BARNEY LLC
SEC 8-68191

Filing source

Form ADV 2073234 · Mar 24, 2026 · Schedule D 7.B.(1), fund 805-7518985019

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Houman Ashrafian Executive
Kate Bingham Executive
N/A Sv Bco I Gp Llp Director, Executive
N/A Sv Health Managers Llp Promoter
Nicola Trbovic Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
71 Kingsway
London, X0, WC2B 6ST